Contact | Print version | PDF version | Send article | RSS feed

OctoPlus wins new drug delivery evaluation contract for two compounds

08 Jun 2009 - As part of the Company's strategic focus on developing controlled release formulations for clients, OctoPlus N.V. announced that it has signed a new drug delivery technology evaluation contract for two compounds with a European biotech company. This is the eighth client for which OctoPlus will work on a controlled release formulation.
 
Under the contract OctoPlus will evaluate the feasibility of two controlled release formulations that combine the active ingredients of the client with OctoPlus' proprietary drug delivery technology. If the evaluations are successful, the contract may progress to a full process development, manufacturing and licensing agreement.